AV Ivermectin
(Die Seite wurde neu angelegt: „{{tp|p=32458795|t=2020. Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.|pdf=|usr=007}} {{tp|p=32479893…“)
Zum nächsten Versionsunterschied →
Version vom 27. Juni 2020, 21:03 Uhr
32458795 2020. Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2.
32479893 2020. Ivermectin: repurposing a multipurpose drug for Venezuela's humanitarian crisis.
32533071 2020. Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen.
32473642 2020. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
32330482 ä. Ivermectin and COVID-19: a report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors responses
32251768 2020. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
32283237 ä. Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment?
32322397 2020. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance
32314704 2020. Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
32378737 2020. The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
